Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-26

Clinical Trial Update: Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 trial update on atacicept for systemic lupus erythematosus reports efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atacicept (atacicept)

Snippet

Sponsor: EMD Serono | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: COMPLETED | Results posted: 2017-10-26